<DOC>
	<DOCNO>NCT03038646</DOCNO>
	<brief_summary>- To evaluate pharmacokinetic ( PK ) profile MIN-l0l follow administration modify release ( MR ) formulations MIN-l0l healthy male female subject - To select 1 MR formulation use feed state - To evaluate effect food bioavailability MIN-l0l select MR formulation</brief_summary>
	<brief_title>A Pharmacokinetic Study Modified Release ( MR ) Formulations MIN-101 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Confirmed CYP 2D6 extensive metaboliser genotype 2 . Subject give voluntary write informed consent performance study related procedure 3 . Must 18 45 year age , inclusive 4 . Subject must healthy male female indicate protocol 5 . Agree abstain medication ( except allow birth control 21 day first dose MIN101 6 . Subject agree use method birth control outline protocol 7 . Must willing able communicate participate whole study . 8 . Willing eat food supply throughout study . 1 . A history clinically significant gastrointestinal disease , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic psychiatric disease condition , opinion principle investigator , would jeopardize safety subject impact validity study result 2 . Acute diarrhoea constipation 7 day predict first study day . 3 . Subject donate blood within 90 day plasma within 30 day study dose 4 . Regular alcohol consumption male &gt; 21 unit per week Females &gt; 14 unit per week ( 1 Unit = 1/2 pint beer , 25 mL 40or 125 mL glass wine ) 5 . Subject borderline long QTc Fridericia interval define screening reading &gt; 430 msec male &gt; 440 female personal familial history long QT syndrome 6 . Subject participate clinical trial within 90 day prior study initiation 7 . Females pregnant breast feed 8 . Subject use prescription medication overthecounter ( OTC ) medication , include vitamin supplement , within 21 day prior day l 9 . Subject treat known P450 206 3A4 enzyme alter drug within 30 day prior study 10 . Subject smoke used nicotine product within 2 month prior study 11 . Subject sought advice refer GP counsellor abuse misuse alcohol , nonmedical drug , medicinal drug substance abuse , e.g . solvent 12 . Subject positive blood screen HIV , Hepatitis B surface antigen ( HBsAg ) , Hepatitis C Antibody 13 . Any current previous use drug opiate , cocaine , ecstasy , intravenous amphetamine and/or positive urine screen alcohol drug abuse . Subjects admit occasional past use cannabis exclude long negative drugsofabuse test abstinent cannabis use least 3 month 14 . Subject current uncontrolled intercurrent illness ( i.e. , active infection ) clinically significant illness within last 30 day prior Day 1 15 . Subject major surgery within 28 day study entry , 12 month prior study gastrointestinal surgery . 16 . Failure satisfy investigator fitness participate reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Food Effect</keyword>
</DOC>